PMC:7307149 / 10608-10885 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T66","span":{"begin":80,"end":83},"obj":"Body_part"}],"attributes":[{"id":"A66","pred":"fma_id","subj":"T66","obj":"http://purl.org/sig/ont/fma/fma84795"}],"text":"the top presenters of conserved peptides. Conversely, we note that 56 different HLA alleles demonstrated no appreciable binding affinity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other h"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T58","span":{"begin":171,"end":179},"obj":"Disease"}],"attributes":[{"id":"A58","pred":"mondo_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"the top presenters of conserved peptides. Conversely, we note that 56 different HLA alleles demonstrated no appreciable binding affinity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other h"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T109","span":{"begin":32,"end":40},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T110","span":{"begin":182,"end":190},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T111","span":{"begin":203,"end":204},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"the top presenters of conserved peptides. Conversely, we note that 56 different HLA alleles demonstrated no appreciable binding affinity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other h"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T56","span":{"begin":32,"end":40},"obj":"Chemical"},{"id":"T57","span":{"begin":182,"end":190},"obj":"Chemical"}],"attributes":[{"id":"A56","pred":"chebi_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A57","pred":"chebi_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"the top presenters of conserved peptides. Conversely, we note that 56 different HLA alleles demonstrated no appreciable binding affinity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other h"}

{"project":"LitCovid-PubTator","denotations":[{"id":"227","span":{"begin":171,"end":181},"obj":"Species"}],"attributes":[{"id":"A227","pred":"tao:has_database_id","subj":"227","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"the top presenters of conserved peptides. Conversely, we note that 56 different HLA alleles demonstrated no appreciable binding affinity (\u003c500 nM) to any of the conserved SARS-CoV-2 peptides, suggesting a concomitant lack of potential for cross-protective immunity from other h"}